Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000834237-21-007057
Filing Date
2021-02-02
Accepted
2021-02-02 15:13:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 us8776191061_020221.txt SC 13G 11443
  Complete submission text file 0000834237-21-007057.txt   13150
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 2280 INWOOD ROAD DALLAS TX 75235
Business Address 2280 INWOOD ROAD DALLAS TX 75235 (214) 612-0000
Taysha Gene Therapies, Inc. (Subject) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91724 | Film No.: 21580776
SIC: 2836 Biological Products, (No Diagnostic Substances)